reglab/statecodes huggingface dataset:
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-023 - TRAINING FOR AN AUTHORIZED MEDICAL PHYSICIST

Current through June 17, 2024
Other than provided in 180 NAC 7-026 the licensee must require the
	 authorized medical physicist to be:
(A) An individual who is certified by a
  specialty board whose certification process has been recognized by the
  Department, the NRC or an Agreement State and who meets the requirements of 180
  NAC 7-0234(C). The names of board certifications that have been recognized by
  an Agreement State or the NRCare posted on the NRC's Medical Uses Licensee
  Toolkit website. To have its certification process recognized, a specialty
  board must require all candidates for certification to:
(i) Hold a master's or doctor's degree in
  physics, medical physics, other physical science, engineering, or applied
  mathematics from an accredited college or university;
(ii) Have two years of full-time practical
  training or supervision experience in medical physics:
(1) Under the supervision of a medical
  physicist who is certified in medical physics by a specialty board whose
  certification process has been recognized under this section by the Department,
  an Agreement State or the NRC; or
(2) In a clinical radiation facilities
  providing high energy, external beam therapy (photons and electrons with
  energies greater than or equal to one million electron volts) and brachytherapy
  services under the direction of physicians who meet the requirements for
  authorized users in 180 NAC 7-026, 7-063 or 7-084; and
(iii) Pass an examination, administered by
  diplomates of the specialty board, which assesses knowledge and competence in
  clinical radiation therapy, radiation safety, calibration, quality assurance,
  and treatment planning for external beam therapy, brachytherapy, and
  stereotactic radiosurgery; or
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-024 - TRAINING FOR AN AUTHORIZED NUCLEAR PHARMACIST

Current through June 17, 2024
The licensee must require the authorized nuclear pharmacist to be a
	 pharmacist who:
(A) Is certified by a
  specialty board whose certification process has been recognized by an Agreement
  State or the NRC. The names of the board certifications that have been
  recognized by an Agreement State or the NRC are posted on the NRC Medical Uses
  Licensee Toolkit website. To have its certification process recognized, a
  specialty board must require all candidates for certification to:
(i) Have graduated from a pharmacy program
  accredited by the Accrediation Council on Pharmaceutical Education, previously
  named the American Council on Pharmaceutical Education, or have passed the
  Foreign Pharmacy Graduate Examination Committee examination;
(ii) Hold a current, active license to
  practice pharmacy;
(iii) Provide
  evidence of having acquired at least 4,000 hours of training or experience, or
  both in nuclear pharmacy practice. Academic training may be substituted for no
  more than 2,000 hours of the required training and experience; and
(iv) Pass an examination in nuclear pharmacy
  administered by diplomates of the specialty board, which assesses knowledge and
  competency in procurement, compounding, quality assurance, dispensing,
  distribution, health and safety, radiation safety, provision of information and
  consultation, monitoring patient outcomes, research and development;
  or
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-025 - TRAINING AND TECHNICAL REQUIREMENT FOR NUCLEAR MEDICINE TECHNOLOGISTS AND RADIATION THERAPISTS

Current through June 17, 2024
025.01
NUCLEAR MEDICINE TECHNOLOGY
The licensee must require
  an individual performing nuclear medicine technology under the supervision of
  an authorized user to be an individual who:
(A) Is certified in:
(i) Nuclear Medicine by the Nuclear Medicine
  Technology Certification Board; or
(ii) Nuclear Medicine by the American
  Registry of Radiologic Technologists (ARRT) with competency in Nuclear
  Medicine;
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-027 - RECENTNESS OF TRAINING

Current through June 17, 2024
The training and experience specified in 180 NAC 7 must have been
	 obtained within seven years preceding the date of license application or the
	 individual must have had related continuing education and experience since the
	 required training and experience was completed.
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-028 - QUALITY CONTROL OF DIAGNOSTIC EQUIPMENT

Current through June 17, 2024
Each licensee must establish written quality control procedures for all
	 diagnostic equipment used for radionuclide studies. As a minimum, quality
	 control procedures and frequencies must be those recommended by equipment
	 manufacturers or procedures, which have been approved by the Department. The
	 licensee must conduct quality control procedures according to written
	 procedures.
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-029 - POSSESSION, USE, AND CALIBRATION OF INSTRUMENTS USED TO MEASURE THE ACTIVITY OF UNSEALED RADIOACTIVE MATERIAL

Current through June 17, 2024
To perform direct measurements according to 180 NAC 7-031, a licensee
	 must:
(A) Possess and use
  instrumentation to measure the activity of unsealed radioactive material before
  administration to each patient or human research subject;
(B) Calibrate the instrumentation according
  to nationally recognized standards or the manufacturer's instructions. The
  calibrations must, at minimum and as appropriate to demonstrate proper
  operation of the instrument, test for:
(i)
  Constancy;
(ii)
  Linearity;
(iii) Accuracy;
  and
(iv) Geometry dependence;
  and
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-030 - CALIBRATION OF SURVEY INSTRUMENTS

Current through June 17, 2024
030.01
REQUIREMENTS.
A licensee must calibrate the survey
  instruments used to show compliance with 180 NAC 7 and 180 NAC 4 before first
  use, annually, and following any repair that affects the calibration. A
  licensee must:
(A) Calibrate all required
  scale readings up to 10 mSv (1000 mrem) per hour with a radiation
  source;
(B) Have each radiation
  survey instrument calibrated:
(i) At energies
  appropriate for use and at annual intervals or after servicing instrument,
  other than battery changes;
(ii)
  For linear scale instruments at two points located approximately one-third and
  two-thirds of full-scale on each scale; for logarithmic scale instruments, at
  mid-range and each decade, and at two points of at least one decade; and for
  digital instruments, at three points between 0.02 and 10 mSv (2 and 1,000 mrem)
  per hour; and
(iii) For dose rate
  instruments, so that an accuracy within plus or minus twenty percent of the
  true radiation dose rate can be demonstrated at each point checked;
  and
(C) Conspicuously
  note on the instrument the date of calibration.
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-031 - DETERMINATION OF DOSAGES OF UNSEALED RADIOACTIVE MATERIAL FOR MEDICAL USE

Current through June 17, 2024
031.01
DOSAGE
  ACTIVITY.
A licensee must determine and record the activity of
  each dosage prior to medical use.
031.02
UNIT DOSAGE
  DETERMINATION.
For unit dosages, this determination must be made
  by:
(A) Direct measurement of radioactivity;
  or
(B) A decay calculation, based
  on the activity or activity concentration determined by:
(i) A manufacturer or preparer licensed
  according to 180 NAC 3-014.10 or equivalent NRC or Agreement State
  requirements;
(ii) A Department,
  NRC, or Agreement State licensee for use in research according to a Radioactive
  Drug Research Committee-approved protocol or an Investigation New Drug (IND)
  protocol accepted by the FDA; or
(iii) A positron emission tomography (PET)
  radioactive drug producer licensed in 180 NAC 3-010.11 or equivalent NRC or
  Agreement State requirements.
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-032 - AUTHORIZATION FOR CALIBRATION, TRANSMISSION AND REFERENCE SOURCES

Current through June 17, 2024
Any person authorized by 180 NAC 7-007 for medical use of radioactive
	 material may receive, possess, and use the following radioactive material for
	 check, calibration, and reference use:
(A) Sealed sources manufactured and
  distributed, or redistributed by persons specifically licensed according to 180
  NAC 3 or equivalent provisions of the NRC, or Agreement State and that do not
  exceed 1.11 GBq (30 mCi) each;
(B)
  Any radioactive material with a half-life of 120 days or less in individual
  amounts not to exceed 555 MBq (15 mCi);
(C) Any radioactive material with a half-life
  greater than 120 days in individual amounts not to exceed the smaller of:
(i) 7.4 MBq (200 µCi); or
(ii) 1000 times the quantities in Appendix B
  of 180 NAC 3; or
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-033 - REQUIREMENTS FOR POSSESSION OF SEALED SOURCES AND BRACHYTHERAPY SOURCES

Current through June 17, 2024
033.01
RADIATION SAFETY AND
  HANDLING INSTRUCTIONS.
A licensee in possession of any sealed
  source or brachytherapy source must follow the radiation safety and handling
  instructions supplied by the manufacturer, or equivalent instructions approved
  by the Department.
033.02
LEAK TESTING.
A licensee in possession of a sealed
  source must:
(A) Test the source for leakage
  according to 180 NAC 1-011; and
(B)
  Test the source for leakage at intervals not to exceed six months or at
  intervals approved by the Department, another Agreement State, or the NRC in
  the Sealed Source and Device Registry.
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-034 - LABELING OF VIALS AND SYRINGES

Current through June 17, 2024
Each syringe and vial containing unsealed radioactive material must be
	 labeled to identify the radioactive drug. Each syringe shield and vial shield
	 must also be labeled unless the label on the syringe or vial is visible when
	 shielded.
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-035 - VIAL AND SYRINGE SHIELDS

Current through June 17, 2024
035.01
VIALS CONTAINING RADIOACTIVE DRUGS.
A licensee must
  require each individual preparing or handling a vial containing a radioactive
  drug to keep the vial in a vial shield.
035.02
SYRINGES CONTAINING
  RADIOACTIVE MATERIAL.
A licensee must:
(A) Keep syringes containing radioactive
  material to be administered in a shield; and
(B) Require each individual who prepares or
  administers radioactive drugs to use a syringe shield unless the use of the
  shield is contraindicated for that patient or human research
  subject.
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-036 - SURVEYS FOR AMBIENT RADIATION DOSE RATE AND CONTAMINATION

Current through June 17, 2024
A licensee must:
(A) Survey
  with a radiation detection survey instrument:
(i) At the end of each day of use all areas
  where radioactive drugs are routinely prepared for use or administered;
  and
(ii) At least once each week
  all areas where radioactive drugs or radioactive wastes are
  stored;
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-037 - RELEASE OF INDIVIDUALS CONTAINING RADIOACTIVE DRUGS OR IMPLANTS

Current through June 17, 2024
037.01
TOTAL EFFECTIVE DOSE
  EQUIVALENT TO ANOTHER INDIVIDUAL.
A licensee may authorize the
  release from its control of any individual who has been administered unsealed
  radioactive drugs or implants containing radioactive material if the total
  effective dose equivalent to any other individual from exposure to the released
  individual is not likely to exceed 5 mSv (0.5 rem). NRC's - NUREG-1556, Vol.9
  "Consolidated Guidance About Materials Licenses: Program-Specific Guidance
  About Medical Licenses," describes methods for calculating doses to other
  individuals and contains tables of activities not likely to cause doses
  exceeding 5 mSv (0.5 rem).
037.02
ORAL AND WRITTEN INSTRUCTIONS.
For patients
  administered radioactive material for which a written directive is required, a
  licensee must provide the released individual, or individual's parent or
  guardian with oral and written instructions on actions recommended to maintain
  doses to other individuals ALARA if the total effective dose equivalent to any
  other individual is likely to exceed 1 mSv (0.1 rem). If the dose to a
  breast-feeding infant or child could exceed 1 mSv (0.1 rem) assuming there were
  no interruption of breast-feeding, the instructions must also include:
(A) Guidance on the interruption or
  discontinuation of breast-feeding; and
(B) Information on the potential
  consequences, if any, of failure to follow the guidance.
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-038 - MOBILE MEDICINE SERVICE TECHNICAL REQUIREMENTS

Current through June 17, 2024
A licensee providing mobile nuclear medicine services must:
(A) Transport to each address of use only
  syringes or vials containing prepared drugs or radioactive materials intended
  for reconstitution of radioactive drug kits;
(B) Bring into each location of use all
  radioactive material to be used and, before leaving, remove all unused
  radioactive material and associated radioactive waste;
(C) Secure or keep under constant
  surveillance and immediate control all radioactive material when in transit or
  at an address of use;
(D) Check
  instruments used to measure the activity of unsealed radioactive material for
  proper function before medical use at each address of use or on each day of
  use, whichever is more frequent. At a minimum, the check for proper function
  must include a constancy check;
(E)
  Check survey instruments for consistent response with a dedicated check source
  before use at each client's address;
(F) Prior to leaving a client's address of
  use, perform area surveys and survey for removable contamination in all areas
  of use to ensure compliance with the requirements in 180 NAC 4;
(G) Use radioactive gases only in areas of
  use and under conditions which have been evaluated and approved by the
  Department for compliance with airborne release standards; and
(H) Retain a record of each survey required
  by 180 NAC 7-038, (F) according to 180 NAC 7-097.
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-039 - STORAGE AND CONTROL OF VOLATILES AND GASES

Current through June 17, 2024
039.01
VOLATILE RADIOACTIVE MATERIAL AND RADIOACTIVE GASES.
A
  licensee must store volatile radioactive material and radioactive gases in a
  radiation shield and container.
039.02
MULTI-DOSE
  CONTAINER.
A licensee must store and use a multi-dose container in
  a properly functioning fume hood.
039.03
AIRBORNE
  CONCENTRATIONS.
A licensee who administers radioactive aerosols or
  gases must do so with a system that will keep airborne concentrations within
  the limits prescribed in 180 NAC 4.
039.04
VENTILATION.
The system must either be directly vented to the atmosphere through an air
  exhaust or provide for collection and decay or disposal of the aerosol or gas
  in a shielded container.
039.05
COLLECTION SYSTEM OPERATIONS CHECK.
A licensee must
  check the operation of collection systems monthly and measure the ventilation
  rates in areas of use at intervals not to exceed six months. Records of these
  checks and measurements must be maintained for three years.
039.06
NEGATIVE PRESSURE
  ROOMS.
A licensee must only administer radioactive gases in rooms
  that are at negative pressure compared to surrounding rooms.
039.07
TIME AFTER RELEASE
  CALCULATION.
Before receiving, using, or storing a radioactive
  gas, the licensee must calculate the amount of time needed after a release to
  reduce the concentration in the area of use to the occupational limit listed in
  180 NAC 4, Appendix 4-B. The calculation must be:
(A) Based on the highest activity of gas
  handled in a single container, the air volume of the room, and the measured
  available air exhaust rate;
(B)
  Posted at the area of use and require that, in the case of a gas spill,
  individuals evacuate the room until the posted time has elapsed; and
(C) Recorded and retained for the duration of
  the license.
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-041 - USE OF UNSEALED RADIOACTIVE MATERIAL FOR UPTAKE, DILUTION, AND EXCRETION STUDIES FOR WHICH A WRITTEN DIRECTIVE IS NOT REQUIRED

Current through June 17, 2024
A licensee may use any unsealed radioactive material, in quantities
	 that do not require a written directive, prepared for medical use involving
	 measurements of uptake, dilution, or excretion that is:
(A)
RING RADIOACTIVE
  MATERIA
Obtained from:
(i) A
  manufacturer or preparer licensed according to 180 NAC 3-014.10 or equivalent
  NRC or Agreement State requirements; or
(ii)
A PET
radioactive drug producer licensed under 180 NAC 3-010.11 or equivalent NRC or
  Agreement State requirements; or
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-042 - POSSESSION OF SURVEY INSTRUMENT

Current through June 17, 2024
A licensee authorized to use radioactive material for uptake, dilution,
	 and excretion studies must possess a portable radiation detection survey
	 instrument capable of detecting dose rates over the range of 1 µSv (0.1
	 mrems) per hour to 1000 µSv (100 mrems) per hour. The instrument must be
	 operable and calibrated according to 180 NAC 7-030.
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-043 - TRAINING FOR UPTAKE, DILUTION, AND EXCRETION STUDIES

Current through June 17, 2024
Other than as provided in 180 NAC 7-026, the licensee must require an
	 authorized user of unsealed radioactive material for the uses authorized in 180
	 NAC 7-041 to be a physician who:
(A)
  Is certified by a medical specialty board whose certification process has been
  recognized by the Department, NRC, or an Agreement State. The names of board
  certifications that have been recognized by the NRC or an Agreement State are
  posted on the NRC's Medical Uses Licensee Toolkit website. To have its
  certification process recognized, a specialty board must require all candidates
  for certification to:
(i) Complete 60 hours
  of training and experience in basic radionuclide handling techniques and
  radiation safety applicable to the medical use of unsealed radioactive material
  for uptake, dilution, and excretion studies as described in 180 NAC 7-043(C)(i)
  and (ii); and
(ii) Pass an
  examination, administered by diplomates of the specialty board that assesses
  knowledge and competence in radiation safety, radionuclide handling, and
  quality control; or
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-044 - USE OF UNSEALED RADIOACTIVE MATERIAL FOR IMAGING AND LOCALIZATION STUDIES FOR WHICH A WRITTEN DIRECTIVE IS NOT REQUIRED

Current through June 17, 2024
A licensee may use, for imaging and localization studies, any
	 radioactive material prepared for medical use, in quantities that do not
	 require a written directive as described in 180 NAC 7-019 that is:
(A) Obtained from:
(i) A manufacturer or preparer licensed
  according to 180 NAC 3-014.10 or equivalent NRC or Agreement State;
  or
(ii) A PET radioactive drug
  producer licensed according to 180 NAC 3-010.11 or equivalent NRC or Agreement
  State; or
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-045 - RADIONUCLIDE CONTAMINANTS

Current through June 17, 2024
045.01
LIMITS.
A licensee must not administer to humans a
  radioactive drug containing:
(A) More than
  0.15 kBq of molybdenum-99 per MBq of technetium-99m (0.15 µCi of
  molybdenum-99 per mCi of technetium-99m);
(B) More than 0.02 kBq of strontium-82 per
  MBq of rubidium-82 chloride injection (0.02 µCi of strontium-82 per mCi
  of rubidium-82 chloride injection); or
(C) More than 0.02 kBq of strontium-85 per
  MBq of rubidium-82 chloride injection (0.02 µCi of strontium-85 per mCi
  of rubidium-82 chloride injection).
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-046 - POSSESSION OF SURVEY INSTRUMENTS

Current through June 17, 2024
A licensee authorized to use radioactive material for imaging and
	 localization studies must possess a portable radiation detection survey
	 instrument capable of detecting dose rates over the range of 1 µSv (0.1
	 mrem) per hour to 500 µSv (50 mrem) per hour. If generators, Mo99/Tc99m
	 or Sr82/Rb82, are utilized, a portable radiation measurement survey instrument
	 capable of measuring dose rates over the range 10 µSv (1 mrem) per hour
	 to 10 mSv (1000 mrem) per hour. The instruments must be operable and calibrated
	 according to 180 NAC 7-030.
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-047 - TRAINING FOR IMAGING AND LOCALIZATION STUDIES

Current through June 17, 2024
Other than provided in 180 NAC 7-026, the licensee must require an
	 authorized user of unsealed radioactive material for the uses authorized in 180
	 NAC 7-044 to be a physician who:
047.01
CERTIFICATION.
Is certified by a medical specialty
  board whose certification process has been recognized by an Agreement State or
  the NRC. The names of board certification that have been recognized by the
  Department, an Agreement State or the NRC are posted on the NRC's Medical Uses
  Licensee Toolkit website. To have its certification process recognized, a
  specialty board must require all candidates for certification to:
(A) Complete 700 hours of training and
  experience in basic radionuclide handling techniques and radiation safety
  applicable to the medical use of unsealed radioactive material for imaging and
  localization studies as described in 180 NAC 7-047.03(A)(i) through (A)(ii)(7);
  and
(B) Pass an examination,
  administered by diplomates of the specialty board, which assesses knowledge and
  competence in radiation safety, radionuclide handling, and quality control;
  or
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-048 - USE OF UNSEALED RADIOACTIVE MATERIAL FOR WHICH A WRITTEN DIRECTIVE IS REQUIRED

Current through June 17, 2024
A licensee may use any unsealed radioactive material identified in 180
	 NAC 7-051(B)(i)(2)(f) prepared for medical use and for which a written
	 directive is required that is:
(A)
  Obtained from:
(i) A manufacturer or preparer
  licensed in 180 NAC 3-014.10; or equivalent NRC or Agreement State;
  or
(ii)
A
  PET
radioactive drug producer licensed according to 180 NAC
  3-010.11 or equivalent NRC or Agreement State; or
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-049 - SAFETY INSTRUCTION AND SAFETY PRECAUTIONS

Current through June 17, 2024
049.01
ADDITIONAL SAFETY REQUIREMENTS.
In addition to the
  requirements of 180 NAC 10-003:
(A) A
  licensee must provide radiation safety instruction, initially and at least
  annually, to all personnel caring for patients or human research subjects who
  cannot be released according to 180 NAC 7-037. The instruction must be
  appropriate to the personnel's assigned duties and include:
(i) Patient or human research subject
  control;
(ii) Visitor control, to
  include:
(1) Routine visitation to
  hospitalized individuals according to 180 NAC 4-013.01(A); and
(2) Visitation authorized according to 180
  NAC 4-013.03;
(iii)
  Contamination control;
(iv) Waste
  control; and
(v) Notification of
  the RSO or their designee and the authorized user if the patient or the human
  research subject has a medical emergency or dies; and
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-050 - POSSESSION OF SURVEY INSTRUMENTS

Current through June 17, 2024
A licensee authorized to use radioactive material for which a written
	 directive is required must possess a portable radiation detection survey
	 instrument capable of detecting dose rates over the range of 1 µSv (0.1
	 mrem) per hour to 1,000 µSv (100 mrems) per hour, and a portable
	 radiation measurement survey instrument capable of measuring dose rates over
	 the range of 10 µSv (1 mrem) per hour to 10 mSv (1000 mrems) per hour.
	 The instruments must be operable and calibrated according to 180 NAC
	 7-030.
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-051 - TRAINING FOR USE OF UNSEALED RADIOACTIVE MATERIAL FOR WHICH A WRITTEN DIRECTIVE IS REQUIRED

Current through June 17, 2024
Other than as provided in 180 NAC 7-026, the licensee must require an
	 authorized user of unsealed radioactive material for the uses authorized under
	 180 NAC 7-048 to be a physician who:
(A) Is certified by a medical specialty board
  whose certification process has been recognized by the Department, an Agreement
  State, or the NRC who meets the requirements in 180 NAC 7-051(B)(i)(2)(f) and
  7-051(B)(ii). Specialty Boards whose certification process has been recognized
  by an Agreement State or the NRC are posted on the NRC's Medical Uses Licensee
  Toolkit website. To be recognized, a specialty board must require all
  candidates for certification to:
(i)
  Successfully complete residency training in a radiation therapy or nuclear
  medicine training program or a program in a related medical specialty. These
  residency training programs must include 700 hours of training and experience
  as described in 180 NAC 7-051(B)(i)(1) through 7-051(B)(i)(2)(e). Eligible
  training programs must be approved by the Residency Review Committee of the
  Accreditation Council for Graduate Medical Education or Royal College of
  Physicians and Surgeons of Canada or the Council on Postdoctoral Training of
  the American Osteopathic Association; and
(ii) Pass an examination, administered by
  diplomates of the specialty board, which tests knowledge and competence in
  radiation safety, radionuclide handling, quality assurance, and clinical use of
  unsealed radioactive material for which a written directive is required;
  or
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-052 - TRAINING FOR THE ORAL ADMINISTRATION OF SODIUM IODIDE I-131 IN QUANTITIES LESS THAN OR EQUAL TO 1.22 GIGABECQUERELS (33 MILLICURIES) FOR WHICH A WRITTEN DIRECTIVE IS REQUIRED

Current through June 17, 2024
Other than as provided in 180 NAC 7-026, the licensee must require an
	 authorized user for the oral administration of sodium iodide I-131 in
	 quantities less than or equal to 1.22 GBq (33 mCi), for which a directive is
	 required, to be a physician who:
(A)
  Is certified by a medical specialty board whose certification process includes
  all of the requirements in 180 NAC 7-052(C)(i) and (ii) and whose certification
  has been recognized by the Department, an Agreement State or the NRC. The names
  of board certifications that have been recognized by an Agreement State or the
  NRC are posted on the NRC's Medical Uses Licensee Toolkit website; or
(B) Is an authorized user under 180 NAC
  7-051(A), 7-051(B) for uses listed in 180 NAC 7-051(B)(i)(2)(f)(i) or (ii), 180
  NAC 7-053, or equivalent NRC or Agreement State requirements; or
(C) The physician has:
(i) Successfully completed 80 hours of
  classroom and laboratory training, applicable to the medical use of sodium
  iodide I-131 for procedures requiring a written directive. The training must
  include:
(1) Radiation physics and
  instrumentation;
(2) Radiation
  protection;
(3) Mathematics
  pertaining to the use and measurement of radioactivity;
(4) Chemistry of radioactive material for
  medical use; and
(5) Radiation
  biology;
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-053 - TRAINING FOR THE ORAL ADMINISTRATION OF SODIUM IODIDE 1-131 IN QUANTITIES GREATER THAN 1.22 GIGABECQUERELS (33 MILLICURIES) FOR WHICH A WRITTEN DIRECTIVE IS REQUIRED

Current through June 17, 2024
Other than as provided in 180 NAC 7-026, the licensee must require an
	 authorized user for the oral administration of sodium iodide 1-131 in
	 quantities greater than 1.22 GBq (33 mCi), to be a physician who:
(A) Is certified by a medical specialty board
  whose certification process includes all of the requirements in 180 NAC
  7-053(C)(i) and (ii) and whose certification has been recognized the
  Department, an Agreement State or the NRC. The name of board certifications
  that have been recognized by an Agreement State or the NRC are posted on the
  NRC's Medical Uses Licensee Toolkit website; or
(B) Is an authorized user under 180 NAC
  7-051, for uses listed in 180 NAC 7-051(B)(i)(2)(f)(ii), or equivalent
  Agreement State, or NRC requirements; or
(C) The physician has:
(i) Successfully completed 80 hours of
  classroom and laboratory training, applicable to the medical use of sodium
  iodide I-131 for procedures requiring a written directive; the training must
  include:
(1) Radiation physics and
  instrumentation;
(2) Radiation
  protection;
(3) Mathematics
  pertaining to the use and measurement of radioactivity;
(4) Chemistry of radioactive material for
  medical use; and
(5) Radiation
  biology;
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-054 - TRAINING FOR THE PARENTERAL ADMINISTRATION OF UNSEALED RADIOACTIVE MATERIAL REQUIRING A WRITTEN DIRECTIVE

Current through June 17, 2024
054.01
AUTHORIZED USER.
Other than as provided in 180 NAC
  7-026, the licensee must require an authorized user for the parenteral
  administration requiring a written directive, to be a physician who:
(A) Is an authorized user under 180 NAC 7-051
  for uses listed in 7-051(B)(i)(2)(f)(iii), or equivalent Agreement State or NRC
  requirements;
(B) Is an authorized
  user under 180 NAC 7-063 or 7-084, or equivalent Agreement State or NRC
  requirements and who meets the requirements in 180 NAC 7-054.02; or
(C) Is certified by a medical specialty board
  whose certification process has been recognized by the Department, the NRC or
  an Agreement State under 180 NAC 7-063 or 7-084; and who meets the requirements
  in 180 NAC 7-054.02.
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-055 - USE OF SOURCES FOR MANUAL BRACHYTHERAPY

Current through June 17, 2024
A licensee must use only brachytherapy sources:
(A) Approved in the Sealed Source and Device
  Registry for manual brachytherapy medical use. The manual brachytherapy sources
  may be used for manual brachytherapy uses not explicitly listed in the Sealed
  Source and Device Registry, but must be used according to the radiation safety
  conditions and limitations described in the Sealed Source and Device Registry;
  or
(B) In research to deliver
  therapeutic doses for medical use according to an active Investigational Device
  Exemption (IDE) application accepted by the FDA, provided the requirements of
  180 NAC 7-021, (A) are met.
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-056 - SURVEYS AFTER SOURCE IMPLANT AND REMOVAL

Current through June 17, 2024
The licensee must:
(A)
  Immediately after implanting sources in a patient or a human research subject,
  make a survey to locate and account for all sources that have not been
  implanted;
(B) Immediately after
  removing the last temporary implant source from a patient or a human research
  subject, make a survey of the patient or the human research subject with a
  radiation detection survey instrument to confirm that all sources have been
  removed; and
(C) Retain a record of
  the surveys according to 180 NAC 7-102.
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-057 - BRACHYTHERAPY SOURCES INVENTORY

Current through June 17, 2024
The licensee must:
(A)
  Maintain accountability at all times for all brachytherapy sources in storage
  or use.
(B) Promptly after removing
  sources from a patient or a human research subject, return brachytherapy
  sources to a secure storage area.
(C) Maintain a record of the brachytherapy
  source accountability according to 180 NAC 7-103.
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-058 - SAFETY INSTRUCTION

Current through June 17, 2024
In addition to the requirements of 180 NAC 10-003, the licensee
	 must:
(A) Provide radiation safety
  instruction, initially and at least annually, to personnel caring for a patient
  or human research subjects that are undergoing implant therapy and cannot be
  released under 180 NAC 7-037. The instruction must be commensurate with the
  duties of the personnel and must include the following:
(i) Size and appearance of the brachytherapy
  sources;
(ii) Safe handling and
  shielding instructions;
(iii)
  Patient or human research subject control;
(iv) Visitor control, including both:
(1) Routine visitation of hospitalized
  individual according to 180 NAC 4-013.01; and
(2) Visitation authorized according to 180
  NAC 4-013.01; and
(v)
  Notification of the RSO or their designee, and authorized user if the patient
  or the human research subject dies or has a medical emergency. The licensee
  must also notify the Department according to 180 NAC 7-119 if it is possible
  that any individual could receive exposures in excess of 5 mSv (500 mrem) as a
  result of the deceased's body; and
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-059 - SAFETY PRECAUTIONS FOR PATIENTS OR HUMAN RESEARCH SUBJECTS RECEIVING BRACHYTHERAPY

Current through June 17, 2024
059.01
PATIENT OR HUMAN RESEARCH SUBJECT RECEIVING BRACHYTHERAPY THAT
  CANNOT BE RELEASED.
For each patient or human research subject
  that is receiving brachytherapy that cannot be released according to 180 NAC
  7-037 a licensee must:
(A) Not quarter the
  patient or the human research subject in the same room as an individual who is
  not receiving radiation therapy; and
(B) Visibly post the patient's or human
  research subject's door with a "Caution: Radioactive Materials" sign; and note
  on the door or the patient's or human research subject's chart where and how
  long visitors may stay in the patient's or human research subject's
  room.
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-060 - CALIBRATION MEASUREMENTS OF BRACHYTHERAPY SOURCES

Current through June 17, 2024
060.01
USE PARAMETERS.
Before the first medical use of a
  brachytherapy source a licensee must:
(A)
  Determine the source output or activity using a dosimetry system that meets the
  requirements of 180 NAC 7-072.01;
(B) Determine source positioning accuracy
  within applicators; and
(C) Use
  published protocols currently accepted by nationally recognized bodies to meet
  the requirements of 180 NAC 7-060.01(A) and (B).
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-061 - THERAPY-RELATED COMPUTER SYSTEMS

Current through June 17, 2024
The licensee must perform acceptance testing on the treatment planning
	 system of therapy-related computer systems according to published protocols
	 accepted by nationally recognized bodies. At a minimum, the acceptance testing
	 must include, as applicable, verification of:
(A) The source-specific input parameters
  required by the dose calculation algorithm;
(B) The accuracy of dose, dwell time, and
  treatment time calculations at representative points;
(C) The accuracy of isodose plots and graphic
  displays; and
(D) The accuracy of
  the software used to determine sealed source positions from radiographic
  images.
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-062 - POSSESSION OF SURVEY INSTRUMENT

Current through June 17, 2024
A licensee authorized to use manual brachytherapy sources must possess
	 a portable radiation detection survey instrument capable of detecting dose
	 rates over the range of 1 µSv (0.1 mrem) per hour to 1,000 µSv (100
	 mrems) per hour, and a portable radiation measurement survey instrument capable
	 of measuring dose rates over the range of 10 µSv (1 mrem) per hour to 10
	 mSv (1000 mrems) per hour. The instruments must be operable and calibrated
	 according to 180 NAC 7-030.
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-063 - TRAINING FOR USE OF MANUAL BRACHYTHERAPY SOURCES

Current through June 17, 2024
Other than as provided in 180 NAC 7-026, the licensee must require an
	 authorized user of a manual brachytherapy source for the uses authorized under
	 180 NAC 7-055 to be a physician who:
(A) Is certified by a medical specialty board
  whose certification process has been recognized by the Department, an Agreement
  State or the NRC. The names of board certifications that have been recognized
  by an Agreement State or the NRC are posted on the NRC's Medical Uses Licensee
  Toolkit website. To have its certification process recognized, a specialty
  board must require all candidates for certification to:
(i) Successfully complete a minimum of three
  years of residency training in a radiation oncology program approved by the
  Residency Review Committee of the Accreditation Council for Graduate Medical
  Education or Royal College of Physicians and Surgeons of Canada or the Council
  on Postdoctoral Training of the American Osteopathic Association; and
(ii) Pass an examination, administered by
  diplomates of the specialty board, that tests knowledge and competence in
  radiation safety, radionuclide handling, treatment planning, quality assurance,
  and clinical use manual brachytherapy; or
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-064 - TRAINING FOR OPHTHALMIC USE OF STRONTIUM-90

Current through June 17, 2024
Other than as provided in 180 NAC 7-026, the licensee must require the
	 authorized user of strontium-90 for ophthalmic uses authorized under 180 NAC
	 7-055 to be:
(A) A physician who is an
  authorized user under 180 NAC 7-063 or equivalent NRC or Agreement State
  requirements; or
(B) A physician
  that has:
(i) Completed 24 hours of classroom
  and laboratory training applicable to the medical use of strontium-90 for
  ophthalmic radiotherapy. The training must include:
(1) Radiation physics and
  instrumentation;
(2) Radiation
  protection;
(3) Mathematics
  pertaining to the use and measurement of radioactivity; and
(4) Radiation biology;
  and
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-065 - USE OF SEALED SOURCES FOR DIAGNOSIS

Current through June 17, 2024
065.01
SEALED SOURCES NOT IN MEDICAL DEVICES.
A licensee must
  use only sealed sources that are not in medical devices for diagnostic medical
  uses if the sealed sources are approved in the Sealed Source and Device
  Registry for diagnostic medicine. The sealed sources may be used for diagnostic
  medical uses that are not explicitly listed in the Sealed Source and Device
  Registry but must be used according to the radiation safety conditions and
  limitations described in the Sealed Source and Device Registry.
065.02
MEDICAL DEVICES CONTAINING
  SEALED SOURCES.
A licensee must only use medical devices
  containing sealed sources for diagnostic medical uses if both the sealed
  sources and medical devices are approved in the Sealed Source and Device
  Registry for diagnostic medical uses. The diagnostic medical devices may be
  used for diagnostic medical uses that are not explicitly listed in the Sealed
  Source and Device Registry but must be used according to the radiation safety
  conditions and limitations described in the Sealed Source and Device
  Registry.
065.03
SEALED
  SOURCES AND DEVICES USED IN RESEARCH.
Sealed sources and devices
  for diagnostic medical uses may be used in research according to an active
  Investigational Device Exemption (IDE) application accepted by the FDA provided
  the requirements of 180 NAC 7-021, (A) are met.
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-066 - TRAINING FOR USE OF SEALED SOURCES FOR DIAGNOSIS

Current through June 17, 2024
Other than as provided in 180 NAC 7-026, the licensee must require the
	 authorized user of a diagnostic sealed source or a device authorized under 180
	 NAC 7-065 to be a physician, dentist or podiatrist who:
(A) Is certified by a specialty board whose
  certification process includes all of the requirements in 180 NAC 7-066.03 and
  7-066.04 whose certification has been recognized by, an Agreement State or the
  NRC. The names of board certifications that have been recognized by an
  Agreement State or the NRC are posted on the NRC's Medical Uses Licensee
  Toolkit website; or
(B) Is an
  authorized user for uses listed in 180 NAC 7-044, or equivalent NRC or
  Agreement State requirements; or
(C) Has completed eight hours of classroom
  and laboratory training in basic radionuclide handling techniques specifically
  applicable to the use of the device. The training must include:
(i) Radiation physics and
  instrumentation;
(ii) Radiation
  protection;
(iii) Mathematics
  pertaining to the use and measurement of radioactivity; and
(iv) Radiation biology;
  and
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-067 - USE OF A SEALED SOURCE IN A REMOTE AFTERLOADER UNIT, TELETHERAPY UNIT, OR GAMMA STEREOTACTIC RADIOSURGERY UNIT

Current through June 17, 2024
067.01
APPROVED SEALED SOURCE.
A licensee must only use
  sealed sources:
(A) As approved and as
  provided for in the NRC Sealed Source and Device Registry; or
(B) In research according to an active
  Investigational Device Exemption application accepted by the FDA provided the
  requirements of 180 NAC 7-021, (A) are met.
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-068 - SURVEYS OF PATIENTS AND HUMAN RESEARCH SUBJECTS TREATED WITH A REMOTE AFTERLOADER UNIT

Current through June 17, 2024
068.01
CONFIRMATION OF SOURCE
  REMOVAL.
Before releasing a patient or a human research subject
  from licensee control, a licensee must make a survey of the patient or the
  human research subject and the remote afterloader unit with a portable
  radiation detection survey instrument to confirm that the source or sources has
  been removed from the patient or human research subject and returned to the
  shielded position.
068.02
RECORDS.
A licensee must retain a record of surveys
  according to 180 NAC 7-102.
Nebraska Administrative Code › Topic - HEALTH AND HUMAN SERVICES SYSTEM › Title 180 - CONTROL OF RADIATION › Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL › Section 180-7-069 - INSTALLATION, MAINTENANCE, ADJUSTMENT, AND REPAIR

Current through June 17, 2024
069.01
CONFIRMATION OF SOURCE REMOVAL.
Only a person
  specifically licensed by the NRC or an Agreement State may install, maintain,
  adjust, or repair a remote afterloader unit, teletherapy unit, or gamma
  stereotactic radiosurgery unit that involves work on the source or sources
  shielding, the source or sources driving unit, or other electronic or
  mechanical component that could expose the source or sources, reduce the
  shielding around the source or sources, or compromise the radiation safety of
  the unit or the source or sources.
069.02
LICENSE
  REQUIRED.
Other than LDR remote afterloader units, only a person
  specifically licensed by the Department, the NRC or an Agreement State may
  install, replace, relocate, or remove a sealed source or source contained in
  other remote afterloader units, teletherapy units, or gamma stereotactic
  radiosurgery units.
069.03
LDR REMOTE AFTERLOADER UNIT.
For a LDR remote
  afterloader unit, only a person specifically licensed by the Department, the
  NRC, an Agreement State or an authorized medical physicist may install,
  replace, relocate, or remove a sealed source or sources contained in the
  unit.
069.04
RECORDS.
A licensee must retain a record of the
  installation, maintenance, adjustment, and repair of remote afterloader units,
  teletherapy units, and gamma stereotactic radiosurgery units according to 180
  NAC 7-106.